Drawing for VEVO

USPTO serial 97708768

VEVO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ROACH, APRIL K
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VEVO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

STEPHEN JADIE COATES

STEPHEN JADIE COATES COATES IP LLP3213 W WHEELER ST. #362ATTN: TRADEMARKSSEATTLE, WA 98199

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical research and development; research and development in the field of drug discovery; research and development in the field of biotechnology; consulting services in the field of pharmaceutical research and development, drug discovery, and biotechnology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials, drug discovery, and biotechnology; testing of pharmaceuticals; providing online non-downloadable software using artificial intelligence for testing of pharmaceuticals and for drug discoveryABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 18, 2024MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Apr 18, 2024ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Apr 18, 2024OP.TOPPOSITION TERMINATED NO. 999999—
Apr 18, 2024OP.DOPPOSITION DISMISSED NO. 999999—
Nov 16, 2023OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 16, 2023OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Oct 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2023DOCKASSIGNED TO EXAMINER—
Jan 6, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 5, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 12, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance